Erythropoietin has an antiapoptotic effect after myocardial infarction and stimulates in vitro aortic ring sprouting

Biochemical and Biophysical Research Communications

Volumn 371, Issue 1, 2008, Pages 75-78

  Broberg, Agneta Månsson ^a   Grinnemo, Karl Henrik ^a   Genead, Rami ^a   Danielsson, Christian ^a   Andersson, Agneta B ^a   Wärdell, Eva ^a   Sylvén, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Apoptosis; Erythropoietin; Mouse; Myocardial infarction

Indexed keywords

BROXURIDINE; ERYTHROPOIETIN; HEMOGLOBIN; MATRIGEL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; VASCULOTROPIN 165;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; VASCULAR RING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTA; APOPTOSIS; BIOLOGICAL ASSAY; CAPILLARIES; CELL PROLIFERATION; CELLS, CULTURED; ERYTHROPOIETIN; HUMANS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 42749089999     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.025     Document Type: Article

References (12)

1. Lipsic E., Schoemaker R., van der Meer P., Voors A., van Veldhuisen D., and van Gilst W. Protective effects of erythropoietin in cardiac ischemia. J. Am. Coll. Cardiol. 48 (2006) 2161-2167
2. van der Meer P., Lipsic E., Henning R.H., et al. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur. J. Heart Fail. 6 (2004) 853-859
3. Parsa C.J., Matsumoto A., Kim J., et al. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112 (2003) 999-1007
4. Tramontano A.F., Muniyappa R., Black A.D., et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem. Biophys. Res. Commun. 308 (2003) 990-994
5. Moon C., Krawzyk M., Paik D., Lakatta E.G., and Talan M.I. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc. Drugs Ther. 19 (2005) 243-250
6. van der Meer P., Lipsic E., Henning R.H., et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J. Am. Coll. Cardiol. 46 (2005) 125-133
7. Yla-Herttuala S., and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9 (2003) 694-701
8. Hao X., Månsson-Broberg A., Gustafsson T., Grinnemo K.H., Blomberg P., Siddiqui A.J., Wärdell E., and Sylvén C. Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction. Biochem. Biophys. Res. Commun. 315 (2004) 1058-1063
9. Siddiqui A.J., Blomberg P., Wärdell E., Hellgren I., Eskandarpour M., Islam K.B., and Sylvén C. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem. Biophys. Res. Commun. 310 (2003) 1002-1009
10. Efthimiadou A., Pagonopoulou O., Lambropoulou M., and Nikolettos N.K. Erythropoietin enhances angiogenesis in an experimental cyclosporine A-induced nephrotoxicity model in the rat. Clin. Exp. Pharmacol. Physiol. 34 (2007) 866-869
11. LaMontagne K.R., Butler J., Marshall D.J., Tullai J., Gechtman Z., Hall C., Meshaw A., and Farrell F.X. Recombinant epoietins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol. Cancer Ther. 5 (2006) 347-355
12. Bahlmann F.H., Song R., Boehm S.M., et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoietin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110 (2004) 1006-1012